Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 1
2005 3
2006 1
2007 1
2008 1
2009 1
2010 2
2011 2
2012 2
2013 5
2014 3
2015 2
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer's Disease Drug Candidate.
Lindberg MF, Deau E, Miege F, Greverie M, Roche D, George N, George P, Merlet L, Gavard J, Brugman SJT, Aret E, Tinnemans P, de Gelder R, Sadownik J, Verhofstad E, Sleegers D, Santangelo S, Dairou J, Fernandez-Blanco Á, Dierssen M, Krämer A, Knapp S, Meijer L. Lindberg MF, et al. Among authors: george p. J Med Chem. 2023 Dec 14;66(23):15648-15670. doi: 10.1021/acs.jmedchem.3c01888. Epub 2023 Dec 5. J Med Chem. 2023. PMID: 38051674
Solid-phase syntheses of 6-arylpyridazin-3(2H)-ones.
Salives R, Dupas G, Plé N, Quéguiner G, Turck A, George P, Sevrin M, Frost J, Almario A, Li A. Salives R, et al. Among authors: george p. J Comb Chem. 2005 May-Jun;7(3):414-20. doi: 10.1021/cc049845n. J Comb Chem. 2005. PMID: 15877470
SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms.
Griebel G, Perrault G, Simiand J, Cohen C, Granger P, Depoortere H, Françon D, Avenet P, Schoemaker H, Evanno Y, Sevrin M, George P, Scatton B. Griebel G, et al. Among authors: george p. CNS Drug Rev. 2003 Spring;9(1):3-20. doi: 10.1111/j.1527-3458.2003.tb00241.x. CNS Drug Rev. 2003. PMID: 12595909 Free PMC article. Review.
Discovery and Optimization of Potent and Orally Available CTP Synthetase Inhibitors for Use in Treatment of Diseases Driven by Aberrant Immune Cell Proliferation.
Novak A, Laughton D, Lane R, Blackham E, Thomas J, Chatzopoulou E, Wrigglesworth J, Quddus A, Ahmed S, Cousin D, Duffy L, Dubois N, Unitt J, Orban K, Browne E, Ward M, Mycock D, Ieva M, Bland N, George P, Bourne T, Asnagli H, Birch L, Jones G. Novak A, et al. Among authors: george p. J Med Chem. 2022 Dec 22;65(24):16640-16650. doi: 10.1021/acs.jmedchem.2c01446. Epub 2022 Nov 30. J Med Chem. 2022. PMID: 36449304
Synthesis and biological evaluation of analogues of M6G.
Trécant C, Dlubala A, George P, Pichat P, Ripoche I, Troin Y. Trécant C, et al. Among authors: george p. Eur J Med Chem. 2011 Sep;46(9):4035-41. doi: 10.1016/j.ejmech.2011.05.076. Epub 2011 Jun 12. Eur J Med Chem. 2011. PMID: 21689868
Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors.
Deleuze-Masquéfa C, Gerebtzoff G, Subra G, Fabreguettes JR, Ovens A, Carraz M, Strub MP, Bompart J, George P, Bonnet PA. Deleuze-Masquéfa C, et al. Among authors: george p. Bioorg Med Chem. 2004 Mar 1;12(5):1129-39. doi: 10.1016/j.bmc.2003.11.034. Bioorg Med Chem. 2004. PMID: 14980625
Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)phenyl] amide as histamine H(3) receptor antagonist for the treatment of depression.
Gao Z, Hurst WJ, Czechtizky W, Hall D, Moindrot N, Nagorny R, Pichat P, Stefany D, Hendrix JA, George PG. Gao Z, et al. Among authors: george pg. Bioorg Med Chem Lett. 2013 Dec 1;23(23):6269-73. doi: 10.1016/j.bmcl.2013.09.081. Epub 2013 Oct 3. Bioorg Med Chem Lett. 2013. PMID: 24139584
32 results